Susanne Mangold

发表

Mining the human autoantibody repertoire: Isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma

S. Holland, Lindsey B. Rosen, S. Browne, 2014, mAbs.

Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

R. Kischel, P. Kufer, R. Lutterbuese, 2009, Journal of immunotherapy.

Highly potent anti-SARS-CoV-2 multi-DARPin therapeutic candidates

B. Bosch, A. Lehmann, H. Binz, 2020, bioRxiv.

T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells

M. Friedrich, P. Hoffmann, R. Kischel, 2010, Proceedings of the National Academy of Sciences.

Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells

P. Hoffmann, P. Kufer, T. Raum, 2009, mAbs.

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

A. Gruber, B. Bosch, H. Binz, 2022, Nature biotechnology.

Multispecific DARPin® therapeutics demonstrate very high potency against SARS-CoV-2 variants in vitro

M. Stumpp, A. Bosshart, F. Malvezzi, 2021 .

Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release

M. Friedrich, R. Kischel, P. Kufer, 2009, Journal of immunotherapy.

Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies

J. Fagerberg, P. Kufer, T. Raum, 2010, Cancer Cell International.